Cooper Cancer Institute

Voorhees Township, New Jersey 08043

0 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Cancer of the Breast, Colonic Neoplasms, Colorectal Cancer, Colorectal Neoplasms, ER Positive, Her2 Negative Breast Cancer Patients, Lung Cancer, Neoplasm Metastasis, Neoplasms, Breast, Non Small Cell Lung Carcinoma, Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed
• Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy — Stopped early
• Phase 2 Trial of Bevacizumab in Combination With Pemetrexed — Completed
• A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer — Completed
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed